Introduction
============

Lumbar disc herniation (LDH) is a common orthopedic disease characterized by low back pain and radiating pain, and has become a global health issue ([@b1-etm-0-0-4900]). Treatment of LDH may include methods such as conservative treatment, interventional therapy and surgical treatment, although percutaneous transforaminal endoscopic discectomy (PTED) is clinically preferred ([@b2-etm-0-0-4900]). Intravertebral anesthesia is generally used in PTED. Intravertebral anesthesia, which includes epidural anesthesia, spinal anesthesia, spinal anesthesia combined epidural anesthesia, and sacral anesthesia, is a method of local anesthesia ([@b3-etm-0-0-4900]). Compared with general anesthesia and the use of intravenous opioids, intravertebral anesthesia can more accurately control surgical or postoperative pain with the use of local anesthetics for nerve block, which is beneficial for the recovery of the patient\'s body function. However, the potential neurological complications from intravertebral anesthesia have attracted increasing attention ([@b4-etm-0-0-4900]). Neurological complications of intravertebral anesthesia include transient neurologic syndrome (TNS), cauda equina syndrome and permanent lumbar radiculopathy. Different from cauda equina syndrome, most patients with TNS have certain motor dysfunctions and sensory disturbances. However, nuclear magnetic resonance and electrophysiological examination generally show no abnormalities, which is a challenge in clinical practice ([@b5-etm-0-0-4900],[@b6-etm-0-0-4900]). In this study, patients with LDH were treated with combined spinal-epidural anesthesia or epidural anesthesia. The incidence of postoperative TNS was also observed.

Patients and methods
====================

### General information

From November 2015 to October 2016, 96 patients with LDH were selected in Cangzhou Central hospital. All patients were treated with PTED. The patients were randomly divided into the control group and observation group, with 48 patients each. Inclusion criteria: i) Patients with LDH diagnosed by imaging and discography; ii) patients with varying degrees of low back pain, and positive femoral nerve or sciatic nerve stretching test; and iii) patients or their family members signed the informed consent. Exclusion criteria: Patients with severe osteomalacia, osteoporosis, malignant tumors, severe cardiovascular and cerebrovascular diseases or liver and kidney dysfunction. There were no significant differences in the baseline parameters between the two groups (p\>0.05) ([Table I](#tI-etm-0-0-4900){ref-type="table"}).

### Anesthesia

All the patients were subjected to intramuscular injection of atropine (0.5 mg, SFDA approval no. H4102367; Anyang Jiuzhou Pharmaceutical Co., Ltd., Henan, China). Routine monitoring of changes in SpO~2~, breathing, pulse and blood pressure were performed while patients were in the prone position. Patients in the observation group received epidural anesthesia. The intervertebral space at the top of the lesion area was used to place the epidural tube. Next, a 5 ml mixture of 1% lidocaine (SFDA approval no. H14023559; Jincheng Haisi Pharmaceutical Co., Ltd., Jincheng, China) and 0.375% ropivacaine (SFDA approval no. H20050325; China Resources Pharmaceutical Group Ltd., Beijing, China) was injected. If no adverse reactions occurred, an additional 10 ml of the mixture was injected with the plane controlled below T6-T8. Patients in the control group were treated with combined spinal-epidural anesthesia. The area between L2 and L3 was punctured to place the spinal needle. Clear cerebrospinal fluid outflow indicated smooth backflow. At this point, 2 ml of 1% ropivacaine was injected within 15 sec. The spinal needle was then withdrawn, and an epidural tube was inserted 4-cm long towards the head end. With patients in the supine position, the plane was adjusted to T6. Epidural analgesia was administered to both groups of patients using 0.2 µg/ml sufentanil (SFDA approval no. H20054172; Yichang Humanwell Pharmaceutical Co., Ltd., Yichang, China) and 0.12% ropivacaine with infusion rate of 5 ml/h. The epidural catheter was removed when platelet density was \>100,000/mm^3^, international normalized ratio was \<1.5 and clotting time returned to normal.

### Index detection

Venous blood samples (5 ml) were collected from the two groups of patients before and 7 days after surgery (fasting for at least 8 h), and serum was separated and extracted by centrifugation (Shenzhen Chaojie Experimental Instrument Co., Ltd., Shenzhen, China). After, rabbit monoclonal CD4 (dilution, 1:50; cat. no. 100405) and rabbit monoclonal CD8 antibody (dilution, 1:50; cat. no. 100706), purchased from BioLegend (San Diego, CA, USA), were added and incubated at 4°C for 30 min in the dark. Flow cytometry (BD Biosciences, Franklin Lakes, NJ, USA) was used to detect the levels of CD4^+^ and CD8^+^ cells. The serum levels of interleukin-2 (IL-2) and tumor necrosis factor-α (TNF-α) were determined using an enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer\'s instructions (Thermo Fisher Scientific, Inc., Waltham, MA, USA). A total of 50 µl of standards and serum were added to each well of the reaction plate, and 100 µl of the enzyme-labeled solution was added to each well. After incubation at 37°C for 1 h, plates were washed 5 times. After, chromogenic agent solutions A and B (50 µl each) were added and incubated at room temperature in the dark for 15 min. Next, 50 µl of the stop solution was added. Optical density (OD) values were measured at 450 nm using a microplate reader (Potebio, Jiangsu, China) within 15 min to calculate the concentrations of IL-2 and TNF-α.

### Evaluation criteria

Fasting venous blood samples (5 ml) were collected from patients before and 7 days after surgery to prepare serum samples. The levels of CD4^+^ and CD8^+^ T lymphocyte subsets were measured by flow cytometry. Serum IL-2 and TNF-α concentrations were measured by ELISA.

Lower limb motor function was scored according to Fugl-Meyer Assessment (FMA) ([@b7-etm-0-0-4900]) at 1, 3 and 5 days after surgery. Cooperative motion of lower limb flexor and extensor, reflection activity, coordination ability and speed, and separating motion were included in the scoring system. A total of 0 points indicated that movement could not be carried out, and 2 points indicated that movement could be fully completed. The total score was 34 points. A score of \<32 indicated movement disorder, and scores were negatively correlated with movement disorder. Lower limb sensory scoring was performed according to FMA, and pain, temperature, and touch sensation were included to evaluate sensory disturbance. A total of 0 points indicated no sensation, and 2 points represented normal sensation. The total score was 20 points, and score and sensory disorder were negatively correlated.

Determination of TNS. After surgery, patients showed unilateral or bilateral lower limb movement disorders, sensory disturbances, burning pain and squeezing or radiating pain. If electrophysiological examination showed no abnormalities, the patients were diagnosed with TNS. According to the severity, TNS was divided into different degrees: i) Level I: Obvious unilateral or bilateral movement disorder and sensory disturbance, movement disorder score \<26 points, and sensory disturbance score \<16; ii) Level II: No obvious unilateral or bilateral movement disorder, score ≥26 points, obvious sensory disturbances and sensory disturbance score \<16; and iii) no obvious unilateral or bilateral movement disorder and sensory disturbance, and only the presence of numbness and pain.

### Statistical analysis

Data were analyzed using SPSS 19.0 statistical software (SPSS Inc., Chicago, IL, USA). Numerical data are presented as mean ± standard deviation (mean ± SD), and paired t-test was used for intragroup and intergroup comparisons. Categorical data are presented as rate, and were tested by χ^2^ test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### The levels of T lymphocyte subsets and inflammatory factors in the two groups

The levels of T lymphocyte subsets (CD4^+^ and CD8^+^) and inflammatory factors (IL-2 and TNF-α) in the two groups were compared. Before and 1 week after surgery, CD4^+^ levels were: 662.54±62.54, 457.36±47.48 cells/µl; CD8^+^ levels were: 393.58±43.45, 313.74±37.52 cells/µl; IL-2 levels were: 8.43±2.37, 15.68±3.26 pg/ml; and TNF-α levels were: 9.47±3.54, 28.67±3.43 pg/ml in the observation group. At the same time-points, CD4^+^ levels were: 665.36±69.36, 453.46±42.46 cells/µl; CD8^+^ levels were: 394.74±42.48, 312.75±35.47 cells/µl; IL-2 levels were: 8.63±2.48, 15.27±3.23 pg/ml; TNF-α levels were: 9.38±3.17, 27.85±3.52 pg/ml in the control group. The serum levels of CD4^+^ and CD8^+^ cells in the two groups were decreased, and the levels of IL-2 and TNF-α were increased at 7 days after surgery compared with those before surgery (p\<0.05). However, no significant differences were found between the two groups (p\>0.05) ([Figs. 1](#f1-etm-0-0-4900){ref-type="fig"}--[4](#f4-etm-0-0-4900){ref-type="fig"}).

### The incidence rates of TNS within 1 week after surgery

The incidence rates of TNS within 1 week after surgery were compared between the two groups. The incidence rate of TNS in the observation group was significantly lower than that in the control group (p\<0.05) ([Table II](#tII-etm-0-0-4900){ref-type="table"}).

### Lower limb movement disorder scores between the two groups

Lower limb movement disorder scores were compared between the two groups. The scores in the observation group were significantly higher than those in the control group at 1, 3 and 5 days after surgery (p\<0.05) ([Table III](#tIII-etm-0-0-4900){ref-type="table"}).

### Sensory disorder scores between the two groups

Sensory disorder scores were compared between the two groups. The scores in the observation group were significantly higher than those in the control group at 1, 3 and 5 days after surgery (p\<0.05) ([Table IV](#tIV-etm-0-0-4900){ref-type="table"}).

Discussion
==========

LDH is the herniation of the nucleus pulposus caused by changes of water molecules in the nucleus pulposus of the intervertebral disc and the prominent nucleus pulposus can oppress the cauda equina or nerve root to produce pain. LDH mostly occurs in the L4/L5 segment ([@b8-etm-0-0-4900]). Currently, PTED is widely used in clinical practice. By precise puncture and positioning, the lesion can be reached through intervertebral foramen puncture to effectively reduce the pain of patients. In addition, intravertebral anesthesia is performed before surgery. Conscious patients will maintain the function of motor and tactile nerves. Through communication with patients, nerve root damage can be avoided, thereby reducing pain ([@b9-etm-0-0-4900],[@b10-etm-0-0-4900]). Surgical trauma, the nervousness of patients and narcotic drugs can cause a stress response, which in turn inhibits immune function. Therefore, immune dysfunction and associated inflammatory responses will occur ([@b11-etm-0-0-4900]). Stress responses can lead to increased secretion of adrenaline and catechol, resulting in abnormal CD4^+^ and CD8^+^ levels. Therefore, immune function disorders will occur and serum levels of IL-2 and TNF-α will increase to induce inflammation ([@b12-etm-0-0-4900],[@b13-etm-0-0-4900]). In this study, serum CD4^+^ and CD8^+^ levels decreased, and IL-2 and TNF-α levels increased at 1 week after treatment compared with preoperative levels. Moreover, there were no significant differences between the two groups (p\>0.05). These observations can be explained by surgical trauma and anesthesia stimulation. However, combined spinal-epidural anesthesia and epidural anesthesia can cause immune dysfunction and inflammation within a short time period after treatment, and there are no essential differences between them.

Related studies reported that the incidence rate of TNS was 3--33%, which may represent mild toxicity from local anesthetics ([@b14-etm-0-0-4900]). Results from this study showed that TNS was observed in both groups of patients within 1 week after surgery, and the incidence rate of TNS in the observation group was significantly lower than that in the control group (p\<0.05). Puncture at the dura of the spinal nerve root, drug injection, and catheterization were performed in both combined spinal-epidural anesthesia and epidural anesthesia. The operations can cause nerve root injury and anesthetic can easily accumulate and precipitate at the dura of the spinal nerve root to achieve nerve block function. Additionally, the intrathecal vulnerable area is the spinal nerve root reaching the spinal cord, and the nerve fibers are unmyelinated. After local anesthetic injection, anesthetic will spread to the spinal nerve root. In addition, excessive air or salt water will also be injected to increase the pressure within the spinal canal, which in turn oppresses nerves and induces nerve damage ([@b15-etm-0-0-4900],[@b16-etm-0-0-4900]). In addition, puncture is generally performed before the complete drying of disinfection liquid. Therefore, disinfector can easily spread to the spinal canal to damage nerve roots. Compared with epidural anesthesia, operations using combined spinal-epidural anesthesia can cause more severe soft tissue and nerve root injuries ([@b17-etm-0-0-4900]).

In this study, patients in both groups showed lower limb movement disorder and sensory disturbances, and the scores in the observation group were significantly higher than those in the control group at 1, 3 and 5 days after surgery (p\<0.05). This was because all local anesthetics are neurotoxic, and repeated injection can cause high local concentrations. The surface active molecules will aggregate in biofilms to affect the structures of proteins and phospholipids on nerve fiber membranes, resulting in irreversible damage ([@b18-etm-0-0-4900]). Similarly, local anesthetics cause increased intracellular calcium concentrations, and higher calcium concentrations cause greater damage to nerve cells ([@b19-etm-0-0-4900]). Long-term analgesia catheterization can lead to long-term exposure of local nerves to drugs, as well as spinal cord tissue edema. Therefore, patients will present with lower limb numbness, weakness, pain and other symptoms. In combined spinal-epidural anesthesia, local anesthetics are injected directly into the cerebrospinal fluid to act on anterior and posterior roots of the spinal nerve and spinal cord, which in turn lead to even higher local drug concentrations and spinal nerve toxicity. Therefore, nerve damage caused by this method is more severe than that caused by epidural anesthesia alone ([@b20-etm-0-0-4900]).

The safety of intravertebral anesthesia used in the surgical treatment of patients with LDH should be recognized, and this method should not be ignored because of the occurrence of TNS. Proper clinical prevention should be applied to reduce the incidence rate of TNS. Comprehensive assessment should be performed before surgery to determine the application of intravertebral anesthesia. With comprehensive assessment, the use of epidural anesthesia is encouraged. In the case of puncture difficulty, repeated puncture should be avoided to reduce damage of the penetration barrier caused by anesthetics. Soft and effective non-invasive catheters should be used as epidural catheters. The dose of anesthetics should also be controlled. The plane of anesthesia should be controlled in a relatively wide range to avoid excessive concentrations of local anesthetics.

In conclusion, to reduce the incidence rate of TNS and increase the safety of surgery, epidural anesthesia, a form of intravertebral anesthesia, should be applied in the PTED treatment of patients with LDH.

![Comparison of CD4^+^ levels in the two groups of patients before and 1 week after surgery. Flow cytometry showed that the postoperative CD4^+^ levels in the two groups were significantly lower than those preoperatively (p\<0.05). No significant differences were found in the preoperative and postoperative levels between the two groups (p\>0.05). Compared with preoperative levels, \*p\<0.05.](etm-14-04-3112-g00){#f1-etm-0-0-4900}

![Comparison of CD8^+^ levels in the two groups of patients before and 1 week after surgery. Flow cytometry showed that the postoperative CD8^+^ levels in the two groups were significantly lower than those preoperatively (p\<0.05). No significant differences were found in the preoperative and postoperative levels between the two groups (p\>0.05). Compared with preoperative levels, \*p\<0.05.](etm-14-04-3112-g01){#f2-etm-0-0-4900}

![Comparison of IL-2 levels in the two groups of patients before and 1 week after surgery. Postoperative IL-2 levels in the two groups were significantly higher than those preoperatively (p\<0.05). No significant differences were found in the preoperative and postoperative levels between two groups (p\>0.05). Compared with preoperative levels, \*p\<0.05. IL, interleukin.](etm-14-04-3112-g02){#f3-etm-0-0-4900}

![Comparison of TNF-α levels in the two groups of patients before and 1 week after surgery. Postoperative TNF-α levels in the two groups were significantly higher than those preoperatively (p\<0.05). No significant differences were found in the preoperative and postoperative levels between the two groups (p\>0.05). Compared with preoperative levels, \*p\<0.05. TNF-α, tumor necrosis factor-α.](etm-14-04-3112-g03){#f4-etm-0-0-4900}

###### 

Comparison of baseline parameters between the two groups of patients.

  Items                        Observation group (n=48)   Control group (n=48)   t/χ^2^   P-value
  ---------------------------- -------------------------- ---------------------- -------- ---------
  Sex (male/female)            27/21                      25/23                  0.168    0.682
  Age (years)                  40--68                     40--65                          
  Average age (years)          49.56±4.42                 49.85±3.53             0.355    0.723
  Course of disease (months)   18.23±4.75                 18.37±4.38             0.150    0.881
  Types (n, %)                                                                            
    Central type               14 (29.17)                 16 (33.33)                      
    Paracentral type           19 (39.58)                 21 (43.75)             0.849    0.654
  L4-L5 far lateral type       15 (31.25)                 11 (22.92)                      

###### 

Comparison of the incidence rates of TNS between the two groups (n, %).

  Groups        Cases   Level I    Level II    Level III   Incidence rates of TNS
  ------------- ------- ---------- ----------- ----------- ------------------------
  Observation   48      1 (2.08)   2 (4.17)    3 (6.25)    6 (12.50)
  Control       48      4 (8.33)   5 (10.42)   7 (14.58)   16 (33.33)
  χ^2^                                                     4.775
  P-value                                                  0.029

TNS, transient neurologic syndrome.

###### 

Comparison of lower limb movement disorder scores between the two groups.

  Groups        Cases   1 day        3 days       5 days
  ------------- ------- ------------ ------------ ------------
  Observation   48      28.95±1.14   29.36±1.13   31.13±1.12
  Control       48      26.16±1.23   27.73±1.25   29.26±1.17
  t-test                11.526       6.702        7.999
  P-value                 \<0.001    \<0.001      \<0.001

###### 

Comparison of sensory disorder scores between the two groups.

  Groups        Cases   1 day        3 days       5 days
  ------------- ------- ------------ ------------ ------------
  Observation   48      16.84±2.34   17.36±2.33   19.53±1.22
  Control       48      15.76±2.25   16.43±2.15   18.96±1.27
  t-test                2.305        2.032        2.242
  P-value               0.023        0.045        0.027
